CHANDLER, Ariz. — Insys Therapeutics Inc. (INSY) on Friday reported a loss of $123.8 million in its first quarter.
On a per-share basis, the Chandler, Arizona-based company said it had a loss of $1.66. Losses, adjusted for one-time gains and costs, were 55 cents per share.
The specialty pharmaceutical company posted revenue of $7.6 million in the period.
In the final minutes of trading on Friday, the company’s shares hit $3.60. A year ago, they were trading at $6.35.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSY at https://www.zacks.com/ap/INSY